facebook-page-view
Advertisement

Peepul Capital and VenturEast-backed Sresta Natural Bioproducts files DRHP for an IPO

By Ankit Agarwal

  • 11 Jan 2022
Peepul Capital and VenturEast-backed Sresta Natural Bioproducts files DRHP for an IPO
Credit: 123RF.com

Hyderabad-based Sresta Natura Bioproducts, which owns the largest packaged organic food brand 24 Mantra, has filed a draft red herring prospectus (DRHP) with the regulator (Sebi) for an IPO on Tuesday.  

 The issue comprises primary shares worth Rs 50 crore, along with 7.03 million shares to be sold through an offer-from-sale (OFS) from existing investors.  

 Existing investor Peepal Capital will sell up to 2.25 million shares and Ventureast, through three of its funds, will sell about 4.78 million shares through the OFS.  

Advertisement

The company will use up to Rs 31.5 crore of the proceeds from the primary issuance for working capital requirements and Rs 8.75 crore for repayment in part or in full of its borrowings. The remainder of the proceeds may be used for general corporate purposes. 

The company was incorporated in 2004, and is promoted by Rajashekar Reddy Seelam, Renuka Seelam, and Balasubramanian Narayanan, who together own 23.63 per cent in the company.  

The financial backers are Peepul Capital, and the funds will be managed by VentureEast.  

Advertisement

Venture capital (VC) firm VentureEast has invested an aggregate of over Rs 50 crore between 2007 and 2016, and owns 38.06% stake in the company.  

Private equity (PE) firm Peepul Capital has invested an aggregate of close to Rs 58 crore between 2011 and 2016 and owns 35.11% stake in the company.  

The company is engaged in procuring, processing, manufacturing, marketing and research, and also the development of organic food products. Its procurement network included 34,516 farmers, 1.9 lakh acres (includes land under organic conversion) of certified organic land across 12 states in India, 65 vendors and companies, and various aggregators.  

Advertisement

The company has reported close to a 19% increase in its operating revenues, from Rs 262.27 crore in FY20 to Rs 312.06 crore in FY21, which has resulted in a 9.8% growth in its net profit from Rs 9.46 crore in FY20 to Rs 10.39 crore in FY21.  

JM Financial and Axis Capital are the book running lead managers to the issue. 

Advertisement

Share article on

Advertisement
Advertisement